Hanna Taipaleenmäki

Professor

Ludwig-Maximilians-Universität München Medizinische Fakultät

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hanna Taipaleenmäki is a Professor at Ludwig-Maximilians-Universität München Medizinische Fakultät in Germany. Her research focuses on bone metabolism, muscle regeneration, and the roles of various signaling pathways in osteoclast and osteoblast differentiation. Recent articles highlight her work on the effects of Tgif1-deficiency on bone health and the therapeutic potential of parathyroid hormone in breast cancer-related bone loss.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Stefan Kalkhof

GERMANY

View details

Daniel J. Smit

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Noriaki Ono

Associate Professor

The University of Texas Health Science Center at Houston

UNITED STATES

View details

Eric Hesse

GERMANY

View details

Deborah Novack

Professor

Washington University in St. Louis

UNITED STATES

View details

Maximilian Michael Saller

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hanna Taipaleenmäki

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates bone loss in mice

Bone anabolic therapy in breast cancer: is there a role for parathyroid hormone or parathyroid hormone-related protein?

RCOR1 promotes myoblast differentiation and muscle regeneration

Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signaling

Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signaling

The osteoblast in regulation of tumor cell dormancy and bone metastasis

Secreted microRNAs in bone metastasis

Single‐Cell RNA‐Sequencing Leading to Breakthroughs in Musculoskeletal Research

MicroRNAs: Emerging Regulators of Metastatic Bone Disease in Breast Cancer

SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells

Antagonizing microRNA ‐19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice

Muscle and Bone Defects in Metastatic Disease

Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice

Interleukins as Mediators of the Tumor Cell—Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis

Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application

Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment

Collaborators (6)

Stefan Kalkhof

Daniel J. Smit

Noriaki Ono

Eric Hesse

Deborah Novack

Maximilian Michael Saller

Make your next move.